|
|
||||||||
1 Institut Louis Bugnard, Institut National de la Santé et de la Recherche Médicale U 388, Centre Hospitalier Universitaire Rangueil, 31054 Toulouse, France; and 2 Max Delbrück Center for Molecular Medicine, D-13122 Berlin, Germany
In the rat mesangial cell (MC), activation of the bradykinin B2 receptor (B2R) by bradykinin (BK) is associated with both phospholipase C (PLC) and A2 (PLA2) activities and with inhibition of adenosine 3',5'-cyclic monophosphate (cAMP) formation leading to cell contraction. Because cAMP plays an important role in the regulation of gene expression in general, we investigated the effect of increasing the intracellular cAMP concentration ([cAMP]i) in mesangial cells on the B2 mRNA expression, on the density of B2 receptor binding sites, on the BK-induced increase in both the free cytosolic Ca2+ concentration ([Ca2+]i), and in the prostaglandin E2 (PGE2) production. Forskolin, PGE2, and cAMP analog, 8-bromoadenosine 3',5'-cyclic monophosphate (8-BrcAMP), were used to increase [cAMP]i. Twenty-four-hour treatment with forskolin, PGE2, and 8-BrcAMP resulted in significant increases in B2 receptor binding sites, which were inhibited by cycloheximide. The maximum B2 receptor mRNA expression (160% above control) was observed in cells treated during 24 h with forskolin and was prevented by actinomycin D. In contrast, the D-myo-inositol 1,4,5-trisphosphate (IP3) formation and the BK-induced increase in [Ca2+]i, reflecting activation of PLC, were not affected by increased levels of [cAMP]i. However, the BK-induced PGE2 release, reflecting PLA2 activity, was significantly enhanced. These data bring new information regarding the dual signaling pathways of B2 receptors that can be differentially regulated by cAMP.
bradykinin; B2 kinin receptor messenger ribonucleic acid; prostaglandin E2; free cytosolic calcium; adenosine 3',5'-cyclic monophosphate; mesangial cell
This article has been cited by other articles:
![]() |
R. Zamorano, S. Suchindran, and J. V. Gainer 3'-Untranslated region of the type 2 bradykinin receptor is a potent regulator of gene expression Am J Physiol Renal Physiol, February 1, 2006; 290(2): F456 - F464. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Baptista, M. C. W. Avellar, R. C. Araujo, J. L. Pesquero, J. P. Schanstra, J. L. Bascands, J. P. Esteve, A. C. M. Paiva, M. Bader, and J. B. Pesquero Transcriptional Regulation of the Rat Bradykinin B2 Receptor Gene: Identification of a Silencer Element Mol. Pharmacol., December 1, 2002; 62(6): 1344 - 1355. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Armando, M. Jezova, A. V. Juorio, J. A. Terron, A. Falcon-Neri, C. Semino-Mora, H. Imboden, and J. M. Saavedra Estrogen upregulates renal angiotensin II AT2 receptors Am J Physiol Renal Physiol, November 1, 2002; 283(5): F934 - F943. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Böckmann and I. Paegelow Kinins and kinin receptors: importance for the activation of leukocytes J. Leukoc. Biol., November 1, 2000; 68(5): 587 - 592. [Abstract] [Full Text] |
||||
![]() |
G. N. Prado, D. F. Mierke, M. Pellegrini, L. Taylor, and P. Polgar Motif Mutation of Bradykinin B2 Receptor Second Intracellular Loop and Proximal C Terminus Is Critical for Signal Transduction, Internalization, and Resensitization J. Biol. Chem., December 11, 1998; 273(50): 33548 - 33555. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |